Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nervgen Pharma

Clinical trials sponsored by Nervgen Pharma, explained in plain language.

Trials to join now! 1

New drug trial aims to help people walk and move again after spinal cord injury

Disease control Recruiting now

This study is testing an investigational drug called NVG-291 to see if it can help improve nerve signaling and function in people with spinal cord injuries. It will enroll 40 adults with recent (subacute) or long-term (chronic) cervical spinal cord injuries to measure changes in …

Phase: PHASE1, PHASE2 • Sponsor: NervGen Pharma • Aim: Disease control

Last updated Apr 02, 2026 15:03 UTC